Exploiting tolerance processes in transplantation

Science
Herman Waldmann, Stephen P Cobbold

Abstract

The full potential of organ transplantation has not yet been realized because of the hazards associated with the long-term use of immunosuppressive drugs. Modern research into mechanisms of immune tolerance offers the promise of reprogramming the immune system, so as to harness the body's natural tolerance mechanisms in the service of graft acceptance. This would allow the minimization of immunosuppressive treatment and offers the prospect of eventually weaning transplant recipients off their drugs.

References

Dec 1, 1990·European Journal of Immunology·S X QinH Waldmann
Mar 1, 1989·The Journal of Experimental Medicine·S X QinH Waldmann
Apr 3, 1986·Nature·R J Benjamin, H Waldmann
Jan 1, 1994·Journal of Hematotherapy·G Hale, H Waldmann
Feb 12, 1993·Science·S QinH Waldmann
Jun 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M M DurhamC P Larsen
Jun 19, 2002·The Journal of Experimental Medicine·Luis GracaHerman Waldmann
Nov 5, 2002·Nature Immunology·Chun-Yen LinHerman Waldmann
May 10, 2003·Trends in Immunology·Ursula GrohmannPaolo Puccetti
Aug 7, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew L MellorDavid H Munn
Sep 12, 2003·Transplant Immunology·Nicole Suciu-FocaRaffaello Cortesini
Nov 18, 2003·Immunological Reviews·Andrew B AdamsChristian P Larsen
Dec 3, 2003·Nature Medicine·Zihao WuLaurence A Turka
Dec 6, 2003·Transplantation·R E BillinghamP B Medawar
May 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephen P CobboldHerman Waldmann

❮ Previous
Next ❯

Citations

Feb 28, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Nicola J MonkStipo Jurcevic
Dec 11, 2007·Nature Medicine·Olivier JoffreJoost P M van Meerwijk
Oct 2, 2004·Nature Reviews. Immunology·Andrew L Mellor, David H Munn
Sep 9, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Zoltán Fehérvari, Shimon Sakaguchi
Nov 17, 2004·The Journal of Clinical Investigation·Patrick T WalshLaurence A Turka
Apr 4, 2007·The Journal of Clinical Investigation·Carole GuillonneauIgnacio Anegon
Nov 19, 2009·Cell Transplantation·Jun SuzukiZhibin Chen
Jul 29, 2008·Current Opinion in Organ Transplantation·Gerald BrandacherDietmar Fuchs
May 1, 2006·Expert Review of Clinical Immunology·Shuiping JiangGiovanna Lombardi
Sep 23, 2006·Expert Opinion on Biological Therapy·Shuiping JiangJie-Fu Huang
Jul 11, 2013·Current Opinion in Organ Transplantation·Tatsuo Kawai, David H Sachs
Jun 5, 2007·Heart Failure Clinics·Richard N Pierson
Jul 9, 2009·Journal of Cellular and Molecular Medicine·Abdelkrim HmadchaBernat Soria
Aug 15, 2006·Immunological Reviews·Herman WaldmannStephen Cobbold
Oct 3, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S C WoodD K Bishop
Jun 8, 2006·Vox Sanguinis·L D Barber, J A Madrigal
Mar 18, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S GiraudV Thomas-Vaslin
Nov 6, 2008·Developmental Dynamics : an Official Publication of the American Association of Anatomists·David L Stocum, Günther K H Zupanc
Mar 23, 2013·Transplant International : Official Journal of the European Society for Organ Transplantation·Deepak ChandrasekharanKathryn J Wood
Jan 5, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J FangmannA Bachmann
Dec 13, 2012·Annals of the New York Academy of Sciences·Agostinho CarvalhoLuigina Romani
Sep 11, 2010·Current Opinion in Immunology·Adrian R Kendal, Herman Waldmann
Oct 31, 2009·European Journal of Immunology·Pascal ChappertDavid-Alexandre Gross
Nov 6, 2004·Blood Cells, Molecules & Diseases·Katia PerruccioLuigina Romani
Dec 13, 2006·International Immunopharmacology·Julia TsangRobert I Lechler
Oct 24, 2006·Human Immunology·Shuiping JiangJie-Fu Huang
Feb 16, 2006·Seminars in Immunology·Herman WaldmannPaul J Fairchild
Oct 30, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Jan NilssonPrediman K Shah
Nov 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zhu-Xu ZhangRobert Zhong
Dec 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Pascal ChappertDavid-Alexandre Gross

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Immunology
Kathryn J Wood, Shimon Sakaguchi
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Shuiping Jiang, Robert I Lechler
The Journal of Experimental Medicine
Luis GracaHerman Waldmann
© 2022 Meta ULC. All rights reserved